Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...

Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...